Patents by Inventor Isaiah E. Cedillo

Isaiah E. Cedillo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11400161
    Abstract: Provided herein are solid phase methods for the synthesis of conjugated oligomeric compounds and intermediates used in such methods. In particular, the solid phase methods provide for addition of a phosphoramidite functionalized conjugate group to a solid support bound oligomeric compound. The methods also provide an increase in overall yield and a cost benefit over existing methods.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: August 2, 2022
    Assignee: Ionis Pharmaceuticals, Inc.
    Inventors: Isaiah E. Cedillo, Recaldo Carty
  • Publication number: 20210283263
    Abstract: Provided herein are solid phase methods for the synthesis of conjugated oligomeric compounds and intermediates used in such methods. In particular, the solid phase methods provide for addition of a phosphoramidite functionalized conjugate group to a solid support bound oligomeric compound. The methods also provide an increase in overall yield and a cost benefit over existing methods.
    Type: Application
    Filed: October 6, 2017
    Publication date: September 16, 2021
    Applicant: Ionis Pharmaceuticals, Inc.
    Inventors: Isaiah E. Cedillo, Recaldo Carty
  • Patent number: 9701708
    Abstract: Provided herein are methods for the synthesis of oligomeric compounds wherein the standard coupling protocols are modified when coupling bicyclic nucleosides of Formula I. More particularly, the modified coupling protocols provide for a decrease in the ratio of phosphoramidite solution to activator solution in the coupling reagent with an increased contact time. The modified coupling protocols provide for oligomeric compounds having comparable yields to similar oligomeric compounds having modified nucleosides other than bicyclic nucleosides of Formula I.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: July 11, 2017
    Assignee: Ionis Pharmaceuticals, Inc.
    Inventors: Isaiah E. Cedillo, Michael T. Migawa, W. Brad Wan
  • Patent number: 9403865
    Abstract: Provided herein are methods for the solid phase synthesis of oligomeric compounds wherein at least one of the capping steps has been modified. More particularly, methods are provided wherein one or more of the capping steps is omitted or performed using reduced equivalents of acetic anhydride. In certain embodiments, the methods provide an enhanced purity profile. In certain embodiments, the methods provide an increased yield. The methods provided herein also provide at least an economic advantage over currently used methods in that reduced amounts of the mixture of capping reagents are required.
    Type: Grant
    Filed: August 15, 2013
    Date of Patent: August 2, 2016
    Assignees: Ionis Pharmaceuticals, Inc., Genzyme Corporation
    Inventors: Isaiah E. Cedillo, Darren Janczak, Phillip Michael Weaver
  • Publication number: 20150368288
    Abstract: Provided herein are methods for the synthesis of oligomeric compounds wherein the standard coupling protocols are modified when coupling bicyclic nucleosides of Formula I. More particularly, the modified coupling protocols provide for a decrease in the ratio of phosphoramidite solution to activator solution in the coupling reagent with an increased contact time. The modified coupling protocols provide for oligomeric compounds having comparable yields to similar oligomeric compounds having modified nucleosides other than bicyclic nucleosides of Formula I.
    Type: Application
    Filed: January 30, 2014
    Publication date: December 24, 2015
    Applicant: ISIS PHARMACEUTICALS, INC.
    Inventors: Isaiah E. Cedillo, Michael T. Migawa, W. Brad Wan
  • Publication number: 20150218205
    Abstract: Provided herein are methods for the solid phase synthesis of oligomeric compounds wherein at least one of the capping steps has been modified. More particularly, methods are provided wherein one or more of the capping steps is omitted or performed using reduced equivalents of acetic anhydride. In certain embodiments, the methods provide an enhanced purity profile. In certain embodiments, the methods provide an increased yield. The methods provided herein also provide at least an economic advantage over currently used methods in that reduced amounts of the mixture of capping reagents are required.
    Type: Application
    Filed: August 15, 2013
    Publication date: August 6, 2015
    Applicants: Genzyme Corporation, Isis Pharmaceuticals, Inc.
    Inventors: Isaiah E. Cedillo, Darren Janczak, Phillip Michael Weaver
  • Patent number: 9034272
    Abstract: The present invention relates to apparatus and methods for synthesizing oligonucleotides wherein a reaction zone has a variable volume based on the position of a piston, and the piston is adjusted to control the amount of headspace above solid support in the reaction zone. Methods and apparatus that limit the size or existence of the headspace are described.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: May 19, 2015
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Isaiah E. Cedillo, Max N. Moore, Francis J. Ring
  • Publication number: 20120107181
    Abstract: The present invention relates to apparatus and methods for synthesizing oligonucleotides wherein a reaction zone has a variable volume based on the position of a piston, and the piston is adjusted to control the amount of headspace above solid support in the reaction zone. Methods and apparatus that limit the size or existence of the headspace are described.
    Type: Application
    Filed: May 28, 2010
    Publication date: May 3, 2012
    Inventors: Isaiah E. Cedillo, Max N. Moore, Francis J. Ring